Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  04:00 2022-12-01 pm EST
2.210 USD   -2.21%
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Development Projects
MT
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
11/30Regeneron Pharmaceuticals' Evkeeza Accepted by US FDA for Priority Review
MT
11/30Transcript : Vertex Pharmaceuticals Incorporated Presents at 5th Annual Everc..
CI
11/30Evkeeza(R) (evinacumab-dgnb) sBLA for Children with Ultra-rare Inherited Form of High C..
CI
11/30Transcript : Regeneron Pharmaceuticals, Inc. Presents at Piper Sandler 34th A..
CI
11/30BioNTech Forms Multi-Target Research Collaboration With Ryvu Therapeutics
MT
11/30BioNTech to Make $21 Million Equity Investment in Ryvu Therapeutics
MT
11/30BioNTech SE and Ryvu Therapeutics S.A. Enters into Global Collaboration to Develop and ..
CI
11/29British Health Regulator Flags Risk Of Serious Eye Reactions To Sanofi-Regeneron's Asth..
MT
11/29Transcript : Regeneron Pharmaceuticals, Inc. Presents at 5th Annual Evercore ..
CI
11/28ECB President Lagarde's Comments That Inflation Will Continue to Rise Weigh on European..
MT
11/28Germany to Ensure BioNTech's COVID-19 Vaccine Partnership in China Continues
MT
11/28Insider Sell: Regeneron Pharmaceuticals
MT
11/27WuXi AppTec Shares Dive on Shareholders' Plan to Pare Stake
DJ
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/23WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility
CI
11/22CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-1..
MT
11/22Regeneron Pharmaceuticals Obtains European Commission's Approval for Libtayo as Monothe..
MT
11/22Regeneron Pharmaceuticals, Inc. Announces Libtayo Approved by the European Commission a..
CI
11/21AbbVie Says Epcoritamab Obtains FDA Priority Review for Treatment of Large B-Cell Lymph..
MT
11/21US FDA Accepts Genmab's Biologics License Application for Epcoritamab for Priority Revi..
MT
11/21AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma
DJ
11/21Genmab A/S Announces U.S. Food and Drug Administration Accepts for Priority Review Biol..
CI
11/21BIONTECH : JP Morgan reiterates its Neutral rating
MD
11/18Pfizer's Updated Omicron Booster Shows Improved Immunity Against New Variants
MT
11/18Shanghai Fosun Pharmaceutical Co., Ltd. Provides Progress Update on the License Agreeme..
CI
11/18Pfizer, BioNTech Says Bivalent COVID-19 Vaccine Shows 'Greater' Response
MT
11/18Pfizer, BioNTech Say Bivalent COVID-19 Booster Showed Improved Immune Response Against ..
MT
11/18Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults
RE
11/18Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demon..
CI
11/18Big Pharma may have to reveal government deals in WHO's draft pandemic rules
RE
11/17Sector Update: Healthcare Stocks Close Slightly Lower
MT
11/17Sector Update: Health Care
MT
11/17CytomX Therapeutics Shares Rally on Regeneron Pact
DJ
11/17Argus Research Adjusts Price Target on Vertex Pharmaceuticals to $340 From $320, Mainta..
MT
11/17Fed Concerns Burden Markets as Investors Scrutinize Earnings Reports, Jobs, Housing Dat..
MT
11/17CytomX, Regeneron to Collaborate on Cancer Therapies
MT
11/17Top Premarket Gainers
MT
11/17Regeneron, CytomX Set Cancer-Therapy Collaboration
DJ
11/17CytomX Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc. Announce Strategic Resear..
CI
11/16Pfizer, BioNTech Begin Phase 1 Study Of New COVID-19 Shot With Longer Protection
MT
11/16Pfizer Inc. and BioNTech SE Advances Next-Generation COVID-19 Vaccine Strategy with Stu..
CI
11/16Insider Sell: Regeneron Pharmaceuticals
MT
11/16Transcript : Regeneron Pharmaceuticals, Inc. Presents at 13th Annual Jefferie..
CI
11/16Transcript : Vertex Pharmaceuticals Incorporated Presents at 13th Annual Jeff..
CI
11/15BIONTECH : UBS gives a Neutral rating
MD
11/14Pengana International Equities' Portfolio Returns 3.7% in October
MT
11/14William Blair Starts Genmab at Market Perform
MT
11/14BioNTech to Set Up mRNA Manufacturing Facility in Singapore
MT
11/14Chinese Government Eyes BioNTech's COVID-19 Jab For Emergency Use By Foreigners
MT
11/13BioNTech Acquires Singapore Facility to Produce mRNA Vaccines
DJ
11/13BioNTech's Singapore Unit To Purchase Novartis' Local Manufacturing Site In Asian Expan..
MT
11/13Germany's BioNTech says to set up mRNA vaccine facility in Singapore
RE
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/11Guggenheim Lowers Price Target on Regeneron Pharmaceuticals to $915 From $925, Maintain..
MT
11/11Regeneron, Sanofi Say European Medicines Agency Committee Recommends Approval of Dupixe..
MT
11/11Regeneron, Sanofi Get CHMP Backing for Dupixent in Prurigo Nodularis
DJ
11/11Regeneron Pharmaceuticals, Inc Announces Dupixent« Recommended for EU Approval by the C..
CI
11/10European ADRs Surge Higher as Global Markets React to US Inflation Data
MT
11/10SVB Securities Adjusts Price Target on Genmab A/S to $33 From $31, Maintains Market Per..
MT
11/10Pfizer-BioNTech Bivalent COVID-19 Booster Vaccine Receives Marketing Authorization Reco..
MT
11/10European Medicines Agency Panel Backs Pfizer-BioNTech Bivalent COVID-19 Vaccine Booster..
MT
11/10Pfizer and Biontech Receive Positive Chmp Opinion for Omicron Ba.4/Ba.5-Adapted Bivalen..
CI
11/10RBC Boosts Price Target on Genmab to DKK3,300 From DKK3,139, Calls Q3 'Solid,' Maintain..
MT
11/09Insider Sell: Vertex Pharmaceuticals
MT
11/09Regeneron Pharmaceuticals' Libtayo Combination Therapy Gets FDA Approval to Treat Non-s..
MT
11/09Transcript : Genmab A/S, Nine Months 2022 Earnings Call, Nov 09, 2022
CI
11/09Genmab A/S Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb..
CI
11/09Tranche Update on Genmab A/S's Equity Buyback Plan announced on March 1, 2021.
CI
11/09BioNTech, Pfizer Agree to Delivery Amendment in EU Commission Deal
MT
11/09UK Health Regulator Approves Pfizer, BioNTech Bivalent COVID-19 Vaccine as Booster
MT
11/09Insider Sell: Regeneron Pharmaceuticals
MT
11/08Regeneron Pharmaceuticals, Inc. Announces Libtayo in Combination with Chemotherapy Appr..
CI
11/08Goldman Sachs Adjusts Price Target on BioNTech SE to $177 From $200, Maintains Neutral ..
MT
11/08Morgan Stanley Adjusts Price Target on BioNTech SE to $203 From $194, Maintains Equalwe..
MT
11/08BIONTECH : Berenberg remains its Buy rating
MD
11/08BIONTECH : Gets a Neutral rating from Goldman Sachs
MD
11/07UBS Adjusts Regeneron Pharmaceuticals Price Target to $862 From $823, Maintains Buy Rat..
MT
11/07Sector Update: Health Care Stocks Advance Premarket Monday
MT
11/07BioNTech Raises Full-Year COVID-19 Vaccine Revenue Outlook Despite Delivery Delays; Thi..
MT
11/07BioNTech Seeks M&A Opportunities
CI
11/07Transcript : BioNTech SE, Q3 2022 Earnings Call, Nov 07, 2022
CI
11/07BioNTech Reports Lower Q3 Profit, Revenue; Updates Full-Year COVID-19 Vaccine Revenue O..
MT
11/07BioNTech Reports Lower Q3 Profit, Ups FY22 Vaccine Revenue Guidance
MT
11/07BioNTech SE Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
11/07BioNTech SE Se Revises Its Earnings Guidance for the Full Year 2022
CI
11/04Regeneron Pharmaceuticals, Inc. Updates Results from Two Positive Pivotal Trials Invest..
CI
11/04Amgen Gets Supreme Court Nod to Hear Appeal on Cholesterol Drug Patents
MT
11/04U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents
RE
11/04U.S. Supreme Court to hear Amgen bid to revive Repatha patents
RE
11/04SVB Leerink Adjusts Price Target on Regeneron Pharmaceuticals to $770 From $756, Mainta..
MT
11/04European ADRs Move Higher in Friday Trading
MT
11/04Pfizer, BioNTech's Bivalent COVID-19 Booster Vaccine Shows Higher Immune Response Versu..
MT
11/04Piper Sandler Adjusts Regeneron Pharmaceuticals' Price Target to $765 From $775, Keeps ..
MT
11/04RBC Lowers Regeneron Pharmaceuticals' Price Target to $700 From $702, Keeps Sector Perf..
MT
11/04BioNTech To Import COVID-19 Vaccine In China After Deal Allowing Shots To Expats
MT
11/04Pfizer-BioNTech's Omicron-specific COVID-19 Booster Shows More Efficacy Than Original J..
MT
11/04Pfizer Inc. and BioNTech SE Announces Updated Clinical Data for Omicron Ba.4/Ba.5-Adapt..
CI
11/04Pfizer/BioNTech Omicron booster shows strong response after a month
RE
11/03Danish Biotech Genmab Lifts FY22 Forecast Anew On Continued Darzalex Boost
MT
11/03Insider Sell: Vertex Pharmaceuticals
MT
Upcoming event on INVIVYD, INC.